BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21919705)

  • 1. Developmental definition of MSCs: new insights into pending questions.
    Huang S; Leung V; Peng S; Li L; Lu FJ; Wang T; Lu W; Cheung KM; Zhou G
    Cell Reprogram; 2011 Dec; 13(6):465-72. PubMed ID: 21919705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo.
    Conrad C; Niess H; Huss R; Huber S; von Luettichau I; Nelson PJ; Ott HC; Jauch KW; Bruns CJ
    Circulation; 2009 Jan; 119(2):281-9. PubMed ID: 19118255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Multipotent Stem Cells of Mesenchymal Nature: Cellular Basis, Clinical Relevance, and Implications for Stem Cell Therapy.
    Klein D
    Antioxid Redox Signal; 2021 Jul; 35(3):204-216. PubMed ID: 33167666
    [No Abstract]   [Full Text] [Related]  

  • 5. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.
    Augello A; Kurth TB; De Bari C
    Eur Cell Mater; 2010 Sep; 20():121-33. PubMed ID: 21249629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling.
    Rodríguez R; García-Castro J; Trigueros C; García Arranz M; Menéndez P
    Adv Exp Med Biol; 2012; 741():187-205. PubMed ID: 22457111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twist-ing cell fate: mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis.
    Cakouros D; Raices RM; Gronthos S; Glackin CA
    J Cell Biochem; 2010 Aug; 110(6):1288-98. PubMed ID: 20564230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).
    Prockop DJ
    Clin Pharmacol Ther; 2007 Sep; 82(3):241-3. PubMed ID: 17700588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells in osteoarticular diseases.
    Jorgensen C; Noël D
    Regen Med; 2011 Nov; 6(6 Suppl):44-51. PubMed ID: 21999261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells for clinical application.
    Sensebé L; Krampera M; Schrezenmeier H; Bourin P; Giordano R
    Vox Sang; 2010 Feb; 98(2):93-107. PubMed ID: 19663934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases.
    Chen Y; Yu Q; Hu Y; Shi Y
    Curr Stem Cell Res Ther; 2019; 14(7):579-582. PubMed ID: 31729289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem Cells from the Apical Papilla: A Promising Source for Stem Cell-Based Therapy.
    Kang J; Fan W; Deng Q; He H; Huang F
    Biomed Res Int; 2019; 2019():6104738. PubMed ID: 30834270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cryopreservation on biological and immunological properties of stem cells from apical papilla.
    Ding G; Wang W; Liu Y; An Y; Zhang C; Shi S; Wang S
    J Cell Physiol; 2010 May; 223(2):415-22. PubMed ID: 20082304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells: a friend or foe in immune-mediated diseases.
    Gazdic M; Volarevic V; Arsenijevic N; Stojkovic M
    Stem Cell Rev Rep; 2015 Apr; 11(2):280-7. PubMed ID: 25592610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells.
    Yew TL; Chiu FY; Tsai CC; Chen HL; Lee WP; Chen YJ; Chang MC; Hung SC
    Aging Cell; 2011 Apr; 10(2):349-61. PubMed ID: 21342417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.
    Harrell CR; Gazdic M; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; Volarevic V
    Curr Stem Cell Res Ther; 2019; 14(4):327-336. PubMed ID: 30806325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
    Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
    J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and quality testing of multipotent mesenchymal stromal cell therapeutics for clinical use.
    Bieback K; Kuçi S; Schäfer R
    Transfusion; 2019 Jun; 59(6):2164-2173. PubMed ID: 30882925
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesenchymal stem cells and skin wound repair and regeneration: possibilities and questions.
    Fu X; Li H
    Cell Tissue Res; 2009 Feb; 335(2):317-21. PubMed ID: 19034523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.